RUBEN ALVARO BARTOLOME CONDE
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- IL13R2 PEPTIDE AND ITS USES
- METHODS AND COMPOSITIONS FOR THE TREATMENT OF IL13R2 OVEREXPRESSING
- PEPTIDO IL13RALFA2 Y SUS USOS
- PEPTIDO IL13RALFA2 Y SUS USOS
- ANTIBODY AND USE THEREOF FOR THE TREATMENT OF CANCER
- IL13R2 PEPTIDE AND ITS USES
- METHODS AND COMPOSITIONS FOR THE TREATMENT OF IL13R2 OVEREXPRESSING
- ANTIBODY AND USE THEREOF FOR THE TREATMENT OF CANCER
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF
- AGENTS BINDING SPECIFICALLY TO HUMAN CADHERIN5 HUMAN CADHERIN6 ANDOR HUMAN CADEHERIN20 AND METHOD AND USES THEREOF